CRVS - Corvus Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRVS is currently covered by 7 analysts with an average price target of $7.22. This is a potential upside of $4.31 (148.11%) from yesterday's end of day stock price of $2.91.

Corvus Pharmaceuticals's activity chart (see below) currently has 27 price targets and 35 ratings on display. The stock rating distribution of CRVS is 87.5% BUY and 12.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60.71% with an average time for these price targets to be met of 311.88 days.

Highest price target for CRVS is $21, Lowest price target is $11, average price target is $12.13.

Most recent stock forecast was given by SEAN LEE from HC WAINWRIGHT on 26-Mar-2025. First documented stock forecast 05-Apr-2017.

Currently out of the existing stock ratings of CRVS, 14 are a BUY (87.5%), 2 are a HOLD (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$11

$8.15 (285.96%)

$11

12 days ago
(26-Mar-2025)

0/3 (0%)

$7.65 (228.36%)

Buy

$13

$10.15 (356.14%)

$8

4 months 25 days ago
(13-Nov-2024)

1/2 (50%)

$4.13 (46.56%)

1059

Buy

$3.5

5 months 16 days ago
(22-Oct-2024)

1/1 (100%)

$1.71 (95.53%)

134

Buy

$21

$18.15 (636.84%)

$12

6 months 22 days ago
(16-Sep-2024)

1/4 (25%)

$15.22 (263.32%)

216

Buy

$4

1 years 6 days ago
(01-Apr-2024)

3/4 (75%)

$2.36 (143.90%)

376

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRVS (Corvus Pharmaceuticals) average time for price targets to be met?

On average it took 311.88 days on average for the stock forecasts to be realized with a an average price target met ratio 60.71

Which analyst has the current highest performing score on CRVS (Corvus Pharmaceuticals) with a proven track record?

ROBERT DRISCOLL

Which analyst has the current lower performing score on CRVS (Corvus Pharmaceuticals) with a proven track record?

GRAIG SUVANNAVEJH

Which analyst has the most public recommendations on CRVS (Corvus Pharmaceuticals)?

Robert Driscoll works at WEDBUSH and has 17 price targets and 9 ratings on CRVS

Which analyst is the currently most bullish on CRVS (Corvus Pharmaceuticals)?

Aydin Huseynov with highest potential upside - $18.15

Which analyst is the currently most reserved on CRVS (Corvus Pharmaceuticals)?

Robert Driscoll with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?